UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Effect of Various Stimulants on Cytokine Secretion Profiles in Freshly Isolated Peripheral Blood Mononuclear Cells (PBMC)

The Journal of immunology (1950), 2022-05, Vol.208 (1_Supplement), p.45-45.12

2022

Volltextzugriff (PDF)

The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease

Frontiers in medicine, 2023-04, Vol.10, p.1101501-1101501

2023

Volltextzugriff (PDF)

Mesenchymal Stem Cell Mechanics from the Attached to the Suspended State

Biophysical journal, 2010-10, Vol.99 (8), p.2479-2487

2010

Volltextzugriff (PDF)

ML-0207/ASP8731: A Novel BACH1 Inhibitor That Induces Fetal Hemoglobin in Treatment of Sickle Cell Disease

Blood, 2021-11, Vol.138 (Supplement 1), p.854-854

2021

Volltextzugriff (PDF)

Abstract 7186: In vitro evaluation of myelosuppressive effects of ATRi tuvusertib and ATMi lartesertib (M4076), alone and in combination

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.7186-7186

2024

Volltextzugriff (PDF)

Abstract 4516: Evaluating the chromatin state as a predictive biomarker for BET inhibitor sensitivity in hematological malignancies

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4516-4516

2016

Volltextzugriff (PDF)

Culture of human and mouse mesenchymal cells

Methods in molecular biology (Clifton, N.J.), 2005, Vol.290, p.173

Clarke, Emer

2005

Volltextzugriff (PDF)

Dasatinib Plus Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML) with Resistance or Suboptimal Response to a Prior Tyrosine Kinase Inhibitor (TKI): Phase I Study CA180323

Blood, 2014-12, Vol.124 (21), p.4539-4539

2014

Volltextzugriff (PDF)

Hematopoietic colony-forming cell assays

Methods in molecular biology (Clifton, N.J.), 2007, Vol.407, p.177

2007

Volltextzugriff (PDF)

Climb Every Mountain! Conquering Queensland’s ‘cliff’ Year through Learning Innovation

Literacy information and computer education journal, 2016-03, Vol.7 (1), p.2180-2197

2016

Volltextzugriff (PDF)

Preclinical models of nicotinamide phosphoribosyltransferase inhibitor-mediated hematotoxicity and mitigation by co-treatment with nicotinic acid

Toxicology mechanisms and methods, 2015-03, Vol.25 (3), p.201-211

2015

Volltextzugriff (PDF)

Enrichment of Mesenchymal Progenitor Cells from Mouse Compact Bone

Blood, 2007-11, Vol.110 (11), p.4105-4105

2007

Volltextzugriff (PDF)

Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia

Blood, 1998-12, Vol.92 (11), p.4072-4079

1998

Volltextzugriff (PDF)

Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome

Blood, 1999-10, Vol.94 (7), p.2236-2246

1999

Volltextzugriff (PDF)

Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemia

British journal of haematology, 1998-08, Vol.102 (3), p.860-871

1998

Volltextzugriff (PDF)

Lisofylline inhibits transforming growth factor β release and enhances trilineage hematopoietic recovery after 5-fluorouracil treatment in mice

Cancer research (Chicago, Ill.), 1996, Vol.56 (1), p.105-112

1996

Volltextzugriff (PDF)

Minimal residula disease status as a predictor of relapse after allogenic bone marrow transplantation for children with acute lymphoblastic leukaemia

British journal of haematology, 1998-08, Vol.102 (3), p.860-871

1998

Volltextzugriff (PDF)

Assessment of variables contributing to cyclosporine distribution in blood

Irish journal of medical science, 1990-09, Vol.159 (9-12), p.269-271

1990

Volltextzugriff (PDF)

Examining the training and education potential of the metaverse: Results from an empirical study of next generation SAFe training

Journal of software : evolution and process, 2023-09, Vol.35 (9)

2023

Volltextzugriff (PDF)

GDPR: an impediment to research?

Irish journal of medical science, 2019-11, Vol.188 (4), p.1129-1135

2019

Volltextzugriff (PDF)

Subclinical Myocarditis After Combination Immune Checkpoint Inhibitor Therapy

Circulation. Heart failure, 2021-02, Vol.14 (2), p.e007524-e007524

2021

Volltextzugriff (PDF)

Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implications

EBioMedicine, 2022-03, Vol.77, p.103894-103894, Article 103894

2022

Volltextzugriff (PDF)

What can be learnt from a qualitative evaluation of implementing a rapid sexual health testing, diagnosis and treatment service?

BMJ open, 2021-10, Vol.11 (10), p.e050109-e050109

2021

Volltextzugriff (PDF)

Abstract PD14-07: Bromodomain and Extra-Terminal motif (BET) inhibitors are a rational therapeutic choice for treatment of invasive lobular carcinoma

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.PD14-07-PD14-07

2022

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(32)
Buchkapitel
(1)

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(14)
Humans
(10)
Animals
(5)
Biological And Medical Sciences
(5)
General & Internal Medicine
(5)
Male
(5)
Medicine, General & Internal
(5)
Adolescent
(4)
Female
(4)
Medical Sciences
(4)
Mice
(4)
Cells, Cultured
(3)
Child
(3)
Child, Preschool
(3)
Infant
(3)
Ireland
(3)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Therapy
(3)
Transplantation, Homologous
(3)
Adult
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Effect of Various Stimulants on Cytokine Secretion Profiles in Freshly Isolated Peripheral Blood Mononuclear Cells (PBMC)

The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease

Mesenchymal Stem Cell Mechanics from the Attached to the Suspended State

ML-0207/ASP8731: A Novel BACH1 Inhibitor That Induces Fetal Hemoglobin in Treatment of Sickle Cell Disease

Abstract 7186: In vitro evaluation of myelosuppressive effects of ATRi tuvusertib and ATMi lartesertib (M4076), alone and in combination

Abstract 4516: Evaluating the chromatin state as a predictive biomarker for BET inhibitor sensitivity in hematological malignancies

Culture of human and mouse mesenchymal cells

Dasatinib Plus Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML) with Resistance or Suboptimal Response to a Prior Tyrosine Kinase Inhibitor (TKI): Phase I Study CA180323

Hematopoietic colony-forming cell assays

Climb Every Mountain! Conquering Queensland’s ‘cliff’ Year through Learning Innovation

Preclinical models of nicotinamide phosphoribosyltransferase inhibitor-mediated hematotoxicity and mitigation by co-treatment with nicotinic acid

Minimal Residual Disease Status Before Allogeneic Bone Marrow Transplantation Is an Important Determinant of Successful Outcome for Children and Adolescents With Acute Lymphoblastic Leukemia

Enrichment of Mesenchymal Progenitor Cells from Mouse Compact Bone

Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia

Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome

Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemia

Lisofylline inhibits transforming growth factor β release and enhances trilineage hematopoietic recovery after 5-fluorouracil treatment in mice

Minimal residula disease status as a predictor of relapse after allogenic bone marrow transplantation for children with acute lymphoblastic leukaemia

Assessment of variables contributing to cyclosporine distribution in blood

Examining the training and education potential of the metaverse: Results from an empirical study of next generation SAFe training

GDPR: an impediment to research?

Subclinical Myocarditis After Combination Immune Checkpoint Inhibitor Therapy

Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implications

What can be learnt from a qualitative evaluation of implementing a rapid sexual health testing, diagnosis and treatment service?

Abstract PD14-07: Bromodomain and Extra-Terminal motif (BET) inhibitors are a rational therapeutic choice for treatment of invasive lobular carcinoma

Suchergebnisse filtern